Company Filing History:
Years Active: 2015-2019
Title: Innovations by Inventor Heidi Spratt
Introduction
Heidi Spratt is a notable inventor based in Galveston, TX (US). She has made significant contributions to the field of biomedical research, particularly in the detection of dengue hemorrhagic fever. With a total of 2 patents, her work focuses on developing methods and biomarkers that enhance the diagnosis and understanding of this serious illness.
Latest Patents
Heidi Spratt's latest patents include innovative methods for detecting and analyzing biomarkers associated with dengue hemorrhagic fever. The first patent provides compositions and methods for diagnosing patients at risk of developing dengue hemorrhagic fever (DHF). This invention highlights the importance of the complement factor D to complement factor H (FactorD/FactorH) ratio, along with levels of biomarkers such as IL2, desmoplakin, and high molecular weight albumin. The second patent outlines methods for identifying patients with dengue-like symptoms who are at risk of DHF. This method involves detecting specific biomarkers, including IL-10, fibrinogen, C4A, immunoglobulin, tropomyosin, and three isoforms of albumin, which are utilized in a predictive MARS model.
Career Highlights
Heidi Spratt is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health, particularly in regions affected by dengue fever.
Collaborations
Heidi collaborates with esteemed colleagues such as Allan R Brasier and Adrian Recinos, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Heidi Spratt's contributions to the field of biomedical research, particularly in the detection of dengue hemorrhagic fever, showcase her dedication to improving diagnostic methods. Her innovative patents and collaborations highlight the importance of research in addressing global health challenges.